Exome sequencing (ES) is commonly used to diagnose Mendelian disorders, which occur when pathogenic variant(s) in a gene are ...

CRISPR Therapeutics, whose CEO is Samarth Kulkarni, and Vertex Pharmaceuticals earned the first U.S. Food and Drug ...

David Liu couldn’t sleep after the U.S. Food and Drug Administration cleared the first clinical trial based on his research.

Thalassemia is a serious but preventable genetic blood disorder that affects the body’s ability to produce normal haemoglobin ...

In what she called a shock, columnist Oluwatosin Adesoye learned some parents give birth to children with sickle cell. Then ...

A gene therapy recently approved by the FDA to treat patients with Sickle Cell Anemia is now being administered in St. Louis.

Sickle Cell Disease is a chronic, inherited blood disorder that affects millions of people worldwide. It is best known for causing anaemia, pain episodes, and organ complications, but a lesser-known ...

Sickle cell disease is an autosomal recessive blood disorder that can lead to anaemia. It is caused by a mutation in the haemoglobin gene, which leads to deformation of red blood cells.

Fanconi anemia is an aggressive, life-threatening disorder. Most individuals living with this rare genetic condition, ...

While generally considered benign, sickle cell trait (SCT) is both common and associated with a risk of sudden exertional death. Indeed, all high-level US intercollegiate athletes now face mandatory ...

It has been nearly two years since Pfizer’s sickle cell disease (SCD) therapy Oxbryta was approved in the UK, but patients will now be able to access the treatment after an agreement was reached ...